nicotine Search Results


91
Toronto Research Chemicals nicotinic acid riboside
Nicotinic Acid Riboside, supplied by Toronto Research Chemicals, used in various techniques. Bioz Stars score: 91/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/nicotine/pmc04646395-267-0-6?v=Toronto+Research+Chemicals
Average 91 stars, based on 1 article reviews
nicotinic acid riboside - by Bioz Stars, 2026-07
91/100 stars
  Buy from Supplier

93
Tocris nicotine hydrogen tartrate salt
Nicotine Hydrogen Tartrate Salt, supplied by Tocris, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/nicotine/pm19812239-157-3-22?v=Tocris
Average 93 stars, based on 1 article reviews
nicotine hydrogen tartrate salt - by Bioz Stars, 2026-07
93/100 stars
  Buy from Supplier

91
Thermo Fisher methyl nicotinate
Methyl Nicotinate, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 91/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/nicotine/pm36770603-227-34-37?v=Thermo+Fisher
Average 91 stars, based on 1 article reviews
methyl nicotinate - by Bioz Stars, 2026-07
91/100 stars
  Buy from Supplier

94
Thermo Fisher nicotine ditartrate dihydrate
Nicotine Ditartrate Dihydrate, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/nicotine/pmc08398432-90-0-9?v=Thermo+Fisher
Average 94 stars, based on 1 article reviews
nicotine ditartrate dihydrate - by Bioz Stars, 2026-07
94/100 stars
  Buy from Supplier

94
Thermo Fisher nicotine
Nicotine, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/nicotine/pmc04457636-142-15-17?v=Thermo+Fisher
Average 94 stars, based on 1 article reviews
nicotine - by Bioz Stars, 2026-07
94/100 stars
  Buy from Supplier

94
Toronto Research Chemicals nicotinic acid niacin
Nicotinic Acid Niacin, supplied by Toronto Research Chemicals, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/nicotine/pm27718370-49-3-9?v=Toronto+Research+Chemicals
Average 94 stars, based on 1 article reviews
nicotinic acid niacin - by Bioz Stars, 2026-07
94/100 stars
  Buy from Supplier

90
Toronto Research Chemicals d 4 nicotinic acid
D 4 Nicotinic Acid, supplied by Toronto Research Chemicals, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/nicotine/pmc05900739-20-2-48?v=Toronto+Research+Chemicals
Average 90 stars, based on 1 article reviews
d 4 nicotinic acid - by Bioz Stars, 2026-07
90/100 stars
  Buy from Supplier

86
Toronto Research Chemicals pyridine d4 ethyl nicotinate
Pyridine D4 Ethyl Nicotinate, supplied by Toronto Research Chemicals, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/nicotine/10__1158_slash_1940___6207__capr___15___0380-61-4-6?v=Toronto+Research+Chemicals
Average 86 stars, based on 1 article reviews
pyridine d4 ethyl nicotinate - by Bioz Stars, 2026-07
86/100 stars
  Buy from Supplier

94
Tocris nicotine
Nicotine, supplied by Tocris, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/nicotine/pmc09016044-23-3-7?v=Tocris
Average 94 stars, based on 1 article reviews
nicotine - by Bioz Stars, 2026-07
94/100 stars
  Buy from Supplier

93
Novus Biologicals chrnb4
Chrnb4, supplied by Novus Biologicals, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/nicotine/pm41390005-102-13-16?v=Novus+Biologicals
Average 93 stars, based on 1 article reviews
chrnb4 - by Bioz Stars, 2026-07
93/100 stars
  Buy from Supplier

90
OriGene human β2 subunit
Fig. 1 Nav1.2 channel and the locations of the functionally studied mutations. Note the color-coded four domains (DI–DIV), the positive charges of segment 4 (S4) on DI–DIV, and the inactivation gate (DIII–DIV linker) marked in red. a Linear representation of the full-length Nav1.2 channel with the mutations studied here (red) or previously (gray)7. b Cryo-electron microscopy structure of Nav1.224. The mutations are distributed in the pore module, the four peripheral voltage-sensing domains, the intracellular loops, and the C-terminus. Residues affected by the mutations are shown as sticks.
Human β2 Subunit, supplied by OriGene, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/nicotine/pm35637276-243-19-26?v=OriGene
Average 90 stars, based on 1 article reviews
human β2 subunit - by Bioz Stars, 2026-07
90/100 stars
  Buy from Supplier

90
OriGene chaperone nacho
Fig. 1 Nav1.2 channel and the locations of the functionally studied mutations. Note the color-coded four domains (DI–DIV), the positive charges of segment 4 (S4) on DI–DIV, and the inactivation gate (DIII–DIV linker) marked in red. a Linear representation of the full-length Nav1.2 channel with the mutations studied here (red) or previously (gray)7. b Cryo-electron microscopy structure of Nav1.224. The mutations are distributed in the pore module, the four peripheral voltage-sensing domains, the intracellular loops, and the C-terminus. Residues affected by the mutations are shown as sticks.
Chaperone Nacho, supplied by OriGene, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/nicotine/pm30681854-368-38-41?v=OriGene
Average 90 stars, based on 1 article reviews
chaperone nacho - by Bioz Stars, 2026-07
90/100 stars
  Buy from Supplier

Image Search Results


Fig. 1 Nav1.2 channel and the locations of the functionally studied mutations. Note the color-coded four domains (DI–DIV), the positive charges of segment 4 (S4) on DI–DIV, and the inactivation gate (DIII–DIV linker) marked in red. a Linear representation of the full-length Nav1.2 channel with the mutations studied here (red) or previously (gray)7. b Cryo-electron microscopy structure of Nav1.224. The mutations are distributed in the pore module, the four peripheral voltage-sensing domains, the intracellular loops, and the C-terminus. Residues affected by the mutations are shown as sticks.

Journal: Communications biology

Article Title: Functional correlates of clinical phenotype and severity in recurrent SCN2A variants.

doi: 10.1038/s42003-022-03454-1

Figure Lengend Snippet: Fig. 1 Nav1.2 channel and the locations of the functionally studied mutations. Note the color-coded four domains (DI–DIV), the positive charges of segment 4 (S4) on DI–DIV, and the inactivation gate (DIII–DIV linker) marked in red. a Linear representation of the full-length Nav1.2 channel with the mutations studied here (red) or previously (gray)7. b Cryo-electron microscopy structure of Nav1.224. The mutations are distributed in the pore module, the four peripheral voltage-sensing domains, the intracellular loops, and the C-terminus. Residues affected by the mutations are shown as sticks.

Article Snippet: Co-transfections involving the β2 subunit were performed using 4 μg wild-type or K905N sodium channel α1 subunit, 3 μg human β2 subunit (NCBI Reference Sequence: NM_004588.5; Origene Technologies, Rockville, MD) and 1 μg eGFP.

Techniques: Cryo-Electron Microscopy

Fig. 2 Voltage dependence of activation and inactivation of wild-type (WT) and mutant Nav1.2 channel variants associated with early-infantile (EI) severe/variable/benign, or later-onset (LO) SCN2A epilepsy. a Representative Nav1.2 current traces. Note that only the first 10 ms of the current traces elicited in the voltage range between −80 and +20 mV are shown. The voltage protocol (inset) consisted of 40-ms depolarizing voltage steps, elicited at 1 Hz in 5-mV increments, in the voltage range between −80 and +60 mV, from a holding potential (HP) of −120 mV. Current traces of individual variants were normalized to the same amplitude. Horizontal scale bar: 5 ms. b–e Activation and inactivation curves were obtained by non-linear least-squares fits of Boltzmann equations (Eq. (1)) to normalized conductance (G/Gmax) data of wild-type Nav1.2 (black solid circle) and mutant Nav1.2 channels (colored open circles). See the parameters of the fits in Supplementary Table 3; n values, the number of independent experiments for inactivation and activation, respectively, are shown in parentheses. f Mean half-maximal voltages of activation and inactivation (V0.5,act and V0.5,inact, respectively) of wild-type Nav1.2 (black bar) and mutant Nav1.2 channels (colored open bars). Data for individual cells are shown in open circles. Relative to wild-type, hyperpolarising shifts of the V0.5,act values are consistent with increased channel opening and gain-of-function (GoF), whereas depolarizing shifts are consistent with reduced channel opening and loss-of-function (LoF); hyperpolarising shifts of the V0.5,inact values are consistent with reduced channel availability (LoF), whereas depolarizing shifts are consistent with increased channel availability (GoF). Data shown are mean ± SEM; n values for all variants are shown in b–e. *P < 0.05, one-way ANOVA, followed by Dunnett’s post-hoc test; the detailed statistical evaluation of biophysical characteristics of the variants is shown in Supplementary Table 3.

Journal: Communications biology

Article Title: Functional correlates of clinical phenotype and severity in recurrent SCN2A variants.

doi: 10.1038/s42003-022-03454-1

Figure Lengend Snippet: Fig. 2 Voltage dependence of activation and inactivation of wild-type (WT) and mutant Nav1.2 channel variants associated with early-infantile (EI) severe/variable/benign, or later-onset (LO) SCN2A epilepsy. a Representative Nav1.2 current traces. Note that only the first 10 ms of the current traces elicited in the voltage range between −80 and +20 mV are shown. The voltage protocol (inset) consisted of 40-ms depolarizing voltage steps, elicited at 1 Hz in 5-mV increments, in the voltage range between −80 and +60 mV, from a holding potential (HP) of −120 mV. Current traces of individual variants were normalized to the same amplitude. Horizontal scale bar: 5 ms. b–e Activation and inactivation curves were obtained by non-linear least-squares fits of Boltzmann equations (Eq. (1)) to normalized conductance (G/Gmax) data of wild-type Nav1.2 (black solid circle) and mutant Nav1.2 channels (colored open circles). See the parameters of the fits in Supplementary Table 3; n values, the number of independent experiments for inactivation and activation, respectively, are shown in parentheses. f Mean half-maximal voltages of activation and inactivation (V0.5,act and V0.5,inact, respectively) of wild-type Nav1.2 (black bar) and mutant Nav1.2 channels (colored open bars). Data for individual cells are shown in open circles. Relative to wild-type, hyperpolarising shifts of the V0.5,act values are consistent with increased channel opening and gain-of-function (GoF), whereas depolarizing shifts are consistent with reduced channel opening and loss-of-function (LoF); hyperpolarising shifts of the V0.5,inact values are consistent with reduced channel availability (LoF), whereas depolarizing shifts are consistent with increased channel availability (GoF). Data shown are mean ± SEM; n values for all variants are shown in b–e. *P < 0.05, one-way ANOVA, followed by Dunnett’s post-hoc test; the detailed statistical evaluation of biophysical characteristics of the variants is shown in Supplementary Table 3.

Article Snippet: Co-transfections involving the β2 subunit were performed using 4 μg wild-type or K905N sodium channel α1 subunit, 3 μg human β2 subunit (NCBI Reference Sequence: NM_004588.5; Origene Technologies, Rockville, MD) and 1 μg eGFP.

Techniques: Activation Assay, Mutagenesis

Fig. 4 Action potential firing of the axon initial segment hybrid neuron incorporating Nav1.2 variants in response to synaptic conductance input in DAPC experiments. a Representative action potential firing elicited with ge/gi ratios of 1, 1.5, 2, 2.5, and 3 in the early-infantile (EI)-severe, EI-variable, EI- benign and later-onset (LO) groups. b–e Input–output relationships in the presence of Nav1.2 channel variants (WT, black solid circle; mutants, colored open circles) associated with EI-severe (b), EI-variable (c), EI-benign (d), or later-onset (LO) (e) SCN2A epilepsy. Two-way ANOVA, followed by Dunnett’s post-hoc test, was used to compare the AP firing frequencies elicited by scaled excitatory to inhibitory conductance ratios (ge/gi) in the presence of Nav1.2 variants; asterisks indicate P < 0.05 (see individual P values in Supplementary Table 7). Note the increased firing activity in the early-infantile severe/ variable groups compared to wild-type, whereas later-onset variants result in an almost complete loss of firing. Data shown are mean ± SEM; n, the number of independent experiments between parentheses.

Journal: Communications biology

Article Title: Functional correlates of clinical phenotype and severity in recurrent SCN2A variants.

doi: 10.1038/s42003-022-03454-1

Figure Lengend Snippet: Fig. 4 Action potential firing of the axon initial segment hybrid neuron incorporating Nav1.2 variants in response to synaptic conductance input in DAPC experiments. a Representative action potential firing elicited with ge/gi ratios of 1, 1.5, 2, 2.5, and 3 in the early-infantile (EI)-severe, EI-variable, EI- benign and later-onset (LO) groups. b–e Input–output relationships in the presence of Nav1.2 channel variants (WT, black solid circle; mutants, colored open circles) associated with EI-severe (b), EI-variable (c), EI-benign (d), or later-onset (LO) (e) SCN2A epilepsy. Two-way ANOVA, followed by Dunnett’s post-hoc test, was used to compare the AP firing frequencies elicited by scaled excitatory to inhibitory conductance ratios (ge/gi) in the presence of Nav1.2 variants; asterisks indicate P < 0.05 (see individual P values in Supplementary Table 7). Note the increased firing activity in the early-infantile severe/ variable groups compared to wild-type, whereas later-onset variants result in an almost complete loss of firing. Data shown are mean ± SEM; n, the number of independent experiments between parentheses.

Article Snippet: Co-transfections involving the β2 subunit were performed using 4 μg wild-type or K905N sodium channel α1 subunit, 3 μg human β2 subunit (NCBI Reference Sequence: NM_004588.5; Origene Technologies, Rockville, MD) and 1 μg eGFP.

Techniques: Activity Assay

Fig. 6 The phenotypic spectrum of SCN2A-related disorders. Pink/red boxes indicate phenotypes associated with gain-of-function (GoF) of the Nav1.2 channel, and blue boxes loss-of-function (LoF) phenotypes; Onset refers to age of seizure onset. The phenotypic groups associated with more severe epilepsies are sometimes grouped as SCN2A developmental and epileptic encephalopathies (gray box), which encompasses both GoF and LoF phenotypes. The early-infantile (EI) phenotypes can be considered a spectrum of clinical severity associated with biophysical GoF. While the later-onset (LO) epilepsy phenotypes and ID/ASD without epilepsy are both associated with LoF, it is not clear whether these represent a spectrum of severity (related to partial or total loss of channel function), or are distinct disorders caused by different mechanisms of channel hypofunction (for example pure LoF vs dominant negative effect).

Journal: Communications biology

Article Title: Functional correlates of clinical phenotype and severity in recurrent SCN2A variants.

doi: 10.1038/s42003-022-03454-1

Figure Lengend Snippet: Fig. 6 The phenotypic spectrum of SCN2A-related disorders. Pink/red boxes indicate phenotypes associated with gain-of-function (GoF) of the Nav1.2 channel, and blue boxes loss-of-function (LoF) phenotypes; Onset refers to age of seizure onset. The phenotypic groups associated with more severe epilepsies are sometimes grouped as SCN2A developmental and epileptic encephalopathies (gray box), which encompasses both GoF and LoF phenotypes. The early-infantile (EI) phenotypes can be considered a spectrum of clinical severity associated with biophysical GoF. While the later-onset (LO) epilepsy phenotypes and ID/ASD without epilepsy are both associated with LoF, it is not clear whether these represent a spectrum of severity (related to partial or total loss of channel function), or are distinct disorders caused by different mechanisms of channel hypofunction (for example pure LoF vs dominant negative effect).

Article Snippet: Co-transfections involving the β2 subunit were performed using 4 μg wild-type or K905N sodium channel α1 subunit, 3 μg human β2 subunit (NCBI Reference Sequence: NM_004588.5; Origene Technologies, Rockville, MD) and 1 μg eGFP.

Techniques: Dominant Negative Mutation